Markets:

Overview

News

Currencies

International

Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

133.79 -2.30 (-1.69%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GeneDx Holdings Corp. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Wednesday's session: top gainers and losers ↗

April 30, 2025

Intrigued by the market activity one hour before the close of the markets on Wednesday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

Top stock movements in today's session. ↗

April 30, 2025

Looking for insights into the US markets in the middle of the day on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 30, 2025

Via Benzinga

Earnings Scheduled For April 30, 2025 ↗

April 30, 2025

Via Benzinga

Wednesday's session: gap up and gap down stocks ↗

April 30, 2025

The session on Wednesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Via Chartmill

Why GeneDx Holdings Stock Is Plunging Today ↗

April 30, 2025

Via The Motley Fool

Crude Oil Falls Over 3%; Regulus Therapeutics Shares Spike Higher ↗

April 30, 2025

Via Benzinga

These stocks that are showing activity before the opening bell on Wednesday. ↗

April 30, 2025

Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top gainers and losers in today's pre-market session.

Via Chartmill

S&P 500 Falls 2%; Caterpillar Reports Downbeat Q1 Results ↗

April 30, 2025

Via Benzinga

Topics Stocks

IBD 50 Stock GeneDx Hammered Despite Earnings Beat-And-Raise ↗

April 30, 2025

The company is an expert in using whole genome and exome sequencing to screen for genetic diseases.

Via Investor's Business Daily

Topics Government

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 30, 2025

Via Benzinga

GeneDx Reports First Quarter 2025 Financial Results and Business Highlights

April 30, 2025

From GeneDx

Via Business Wire

Exploring high growth characteristics of GENEDX HOLDINGS CORP (NASDAQ:WGS). ↗

April 23, 2025

UA fundamental and technical analysis of (NASDAQ:WGS): nlocking the high Growth Potential of GENEDX HOLDINGS CORP (NASDAQ:WGS).

Via Chartmill

GeneDx Eyes Global Genomic Leadership With Fabric Genomics Buyout For Up To $51 Million ↗

April 16, 2025

GeneDx (NASDAQ: WSG) to acquire Fabric Genomics, pioneer in AI-powered genomic interpretation, for up to $51 million. Expanding global reach and improving precision diagnostics.

Via Benzinga

IBD 50's GeneDx Inks $84 Million AI-Tied Takeover Deal ↗

April 16, 2025

GeneDx will pay up to $84 million to acquire Fabric Genomics for its AI-powered genomics interpretation platform.

Via Investor's Business Daily

Topics Artificial Intelligence

GeneDx to Acquire Fabric Genomics, Enabling Decentralized, AI-Powered Testing at Global Scale

April 16, 2025

From GeneDx

Via Business Wire

Why GENEDX HOLDINGS CORP (NASDAQ:WGS) could fit Mark Minervini’s high-growth criteria ↗

April 10, 2025

A fundamental and technical analysis of (NASDAQ:WGS): Should you consider GENEDX HOLDINGS CORP (NASDAQ:WGS) for high growth investing?

Via Chartmill

GeneDx to Report First Quarter 2025 Financial Results on Wednesday, April 30, 2025

April 08, 2025

From GeneDx

Via Business Wire

GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication

April 03, 2025

From GeneDx

Via Business Wire

GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 20, 2025

From GeneDx

Via Business Wire

Unlocking the high Growth Potential of GENEDX HOLDINGS CORP (NASDAQ:WGS). ↗

March 20, 2025

Exploring high growth characteristics of GENEDX HOLDINGS CORP (NASDAQ:WGS). A fundamental and technical analysis of (NASDAQ:WGS).

Via Chartmill

Does GENEDX HOLDINGS CORP (NASDAQ:WGS) align with Mark Minervini’s trading strategy? ↗

March 18, 2025

A fundamental and technical analysis of (NASDAQ:WGS): Why the high growth investor may take a look at GENEDX HOLDINGS CORP (NASDAQ:WGS).

Via Chartmill

Fast Company Recognizes GeneDx as One of the World's Most Innovative Companies

March 18, 2025

From GeneDx

Via Business Wire

GeneDx to Showcase Key Research and Innovation at the 2025 American College of Medical Genetics (ACMG) Annual Meeting

March 13, 2025

From GeneDx

Via Business Wire

GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical Analysis

March 13, 2025

From GeneDx

Via Business Wire

SPY Trying To Find A Floor At The 200 SMA; One New Swing ↗

March 08, 2025

In this video lesson I review the day-one of a new rally attempt in the overall market, discuss my new swing trade in a cyber-security leader, and review my tier-one long-term portfolio purchases in my...

Via Talk Markets

Topics Stocks / Equities

GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication

March 04, 2025

From GeneDx

Via Business Wire

Powerful UnR Session As All Four Market Indices Lockstep Rally Into The Close; Bear Trap Set? ↗

February 28, 2025

In this video lesson, I review the overall market, the recent bearish sentiment, and one new swing trade idea for Monday's session.

Via Talk Markets

Topics Stocks / Equities

Landmark Seqfirst-neo Study Showcases the Significant Impact of Genomic Testing in the NICU, Revealing Gaps in Current Protocols

February 24, 2025

From GeneDx

Via Business Wire

Top Biotech GeneDx Catapults 42% After Obliterating Earnings Forecasts ↗

February 18, 2025

GeneDx stock catapulted more than 40% on Tuesday after the top-notch biotech smashed fourth-quarter expectations.

Via Investor's Business Daily

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.